Back to search

National and Kapodistrian University of Athens

Μελέτη της θεραπευτικής επίδρασης της σιλοσταζόλης στη φλεγμονώδη απόκριση και την εξέλιξη της ισχαιμίας άκρου σε μύες

Abstract

dc:description

Introduction: Angiogenesis is a physiological process involving the growth of new blood vessels from pre-existing vessels, with macrophages, and T cells playing an important role in the development of this phenomenon. These cells are also affected by various drugs administered for the treatment of diseases related to the pathological obstruction of blood vessels which, initially target molecules, like the phosphodiesterase inhibitor family.Cilostazol is a selective inhibitor of phosphodiesterase 3A (PDE-3Α), with proven effectiveness in the treatment of intermittent claudication (IC), increasing the distance walked by patients with IC. The drug acts on platelets, vascular smooth muscle cells and endothelial cells by increasing the levels cyclic adenosine monophosphate (cAMP) via the concomitant intracellular PDE-3A inhibition and extracellular adenosine uptake. Using a Peripheral Arterial Disease (PAD) mouse model, the purpose of this study was to investigate the revascularization of ischemic muscles after the induction of surgical hind limb ischemia, as well as the interactions between cilostazol and innate immunity cells, and the effects of the drug on the profile of cytokines produced. Methods: A total of 108 NOD.CB17-Prkdcscid/J and 108 CB17 male mice were used. All animals underwent hind limb ischemia. At the day of surgery (D0), 60 mg/kg of cilostazol were administered to all animals which continued receiving a daily dosage of 30 mg/kg for the next 7 postoperative days. Vehicle was administered daily in the control groups. Serum concentrations of IL-2, IL-4, IL-6, IL-10, IL-17A, TNF and IFN-gamma were measured by flow cytometry on post-surgery days D1, D3, D5, and D7. On D7 Post-mortem Analysis was performed after the administration of 68Ga-RGD. The gastrocnemius muscle was obtained for histological evaluation. Key findings: There was a statistically significant augmentation (p < 0.05) in the concentrations of IL-4, IL-10, IL-6 and IFN-g in cilostazol treated wild type animals while IL-2 was significantly suppressed. In treated immunodeficient animals, TNF, IL-6 and IFN-g presented significant augmentation while the uptake of 68Ga-NODAGA-RGDfK was found significantly lower for both legs in comparison with the control group. No significant difference in the uptake of 68Ga-NODAGA-RGDfK was found in wild type animals.Significance: Cilostazol seems to significantly influence immunity cells in cytokine production altering the type of immunity response by promoting the production of anti-inflammatory cytokines in wild type animals while it helps toward the improvement of immunity response in immunodeficient animals. Conclusions: In conclusion, cilostazol seems to significantly impact on immune cells, mainly affecting cytokine production, thus altering the type of immune response; cilostazol seems to promote the production of anti-inflammatory cytokines and the suppression of IL-2 in wild-type animals, while it helps towards the improvement of immune responses in immunodeficient animals by increasing the secretion of proinflammatory cytokines and IFN-γ, an indication that needs to be further investigated. Regarding the effects of cilostazol on angiogenesis, our results indicate reduced expression of αvβ3 integrin and CD31 receptor in immunodeficient mice, while cilostazol seems to significantly increase angiogenesis in wild type animals during the first post operational week.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Paronis, Efthymios
  • Παρώνης, Ευθύμιος

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47111

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Paronis, Efthymios; Παρώνης, Ευθύμιος. Μελέτη της θεραπευτικής επίδρασης της σιλοσταζόλης στη φλεγμονώδη απόκριση και την εξέλιξη της ισχαιμίας άκρου σε μύες. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/47111